Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RESCATHEME: Linagliptin + Metformin in Prediabetes
NCT04088461Phase 4Completed
- Sponsor
- Universidad de Guanajuato
- Start
- Sep 2016
- Primary completion
- Sep 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of linagliptin in prediabetes, impaired glucose tolerance (IGT), insulin resistance (IR), sponsored by Universidad de Guanajuato. Started Sep 2016; status: completed.
02
Drugs
linagliptin
03
Conditions
prediabetesimpaired glucose tolerance (IGT)insulin resistance (IR)
Beyond the preview
Go deeper on NCT04088461.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04088461.